AAPL   324.87 (-0.08%)
MSFT   184.57 (-0.43%)
GOOGL   1,439.25 (-0.21%)
NVDA   349.16 (-0.42%)
BABA   217.79 (-0.82%)
MU   48.92 (+0.00%)
AMD   52.89 (-1.51%)
GILD   74.16 (-0.32%)
DIS   122.53 (-0.35%)
NFLX   423.05 (-1.25%)
BAC   25.80 (+4.67%)
BA   183.14 (+12.16%)
AAPL   324.87 (-0.08%)
MSFT   184.57 (-0.43%)
GOOGL   1,439.25 (-0.21%)
NVDA   349.16 (-0.42%)
BABA   217.79 (-0.82%)
MU   48.92 (+0.00%)
AMD   52.89 (-1.51%)
GILD   74.16 (-0.32%)
DIS   122.53 (-0.35%)
NFLX   423.05 (-1.25%)
BAC   25.80 (+4.67%)
BA   183.14 (+12.16%)
AAPL   324.87 (-0.08%)
MSFT   184.57 (-0.43%)
GOOGL   1,439.25 (-0.21%)
NVDA   349.16 (-0.42%)
BABA   217.79 (-0.82%)
MU   48.92 (+0.00%)
AMD   52.89 (-1.51%)
GILD   74.16 (-0.32%)
DIS   122.53 (-0.35%)
NFLX   423.05 (-1.25%)
BAC   25.80 (+4.67%)
BA   183.14 (+12.16%)
AAPL   324.87 (-0.08%)
MSFT   184.57 (-0.43%)
GOOGL   1,439.25 (-0.21%)
NVDA   349.16 (-0.42%)
BABA   217.79 (-0.82%)
MU   48.92 (+0.00%)
AMD   52.89 (-1.51%)
GILD   74.16 (-0.32%)
DIS   122.53 (-0.35%)
NFLX   423.05 (-1.25%)
BAC   25.80 (+4.67%)
BA   183.14 (+12.16%)
Log in

NASDAQ:LNDCLandec Stock Price, Forecast & News

$10.94
+0.05 (+0.46 %)
(As of 06/4/2020 09:27 AM ET)
Add
Compare
Today's Range
$10.74
Now: $10.94
$11.11
50-Day Range
$9.50
MA: $10.41
$11.54
52-Week Range
$7.53
Now: $10.94
$12.46
Volume60,057 shs
Average Volume94,234 shs
Market Capitalization$319.23 million
P/E RatioN/A
Dividend YieldN/A
Beta0.98
Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets. It operates through Curation Foods and Lifecore segments. The Curation Foods segment engages in processing, marketing, and selling of vegetable-based salads, and fresh-cut and whole vegetable products primarily under the Eat Smart brand, O branded olive oils and wine vinegars, and Yucatan and Cabo Fresh guacamole and avocado food products, as well as various private labels. It serves retail grocery chains, club stores, and food service operators. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology transfer, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. It sells its products directly to partners in the medical device and pharmaceutical markets. The company was founded in 1986 and is headquartered in Santa Clara, California.
Read More
Landec logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.14 out of 5 stars


Industry, Sector and Symbol

Industry Canned fruits & specialties
Sub-IndustrySpecialty Chemicals
Current SymbolNASDAQ:LNDC
CUSIP51476610
Phone650-306-1650

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$557.56 million
Cash Flow$0.85 per share
Book Value$9.26 per share

Profitability

Net Income$410,000.00

Miscellaneous

Employees736
Market Cap$319.23 million
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive LNDC News and Ratings via Email

Sign-up to receive the latest news and ratings for LNDC and its competitors with MarketBeat's FREE daily newsletter.

Landec (NASDAQ:LNDC) Frequently Asked Questions

How has Landec's stock been impacted by COVID-19 (Coronavirus)?

Landec's stock was trading at $9.54 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, LNDC stock has increased by 14.7% and is now trading at $10.94. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Landec?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Landec in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Landec.

When is Landec's next earnings date?

Landec is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Landec.

How were Landec's earnings last quarter?

Landec Co. (NASDAQ:LNDC) announced its earnings results on Tuesday, March, 31st. The basic materials company reported $0.04 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.01 by $0.03. The basic materials company earned $152.93 million during the quarter, compared to analysts' expectations of $147.15 million. Landec had a negative return on equity of 1.84% and a negative net margin of 3.97%. View Landec's earnings history.

What guidance has Landec issued on next quarter's earnings?

Landec issued an update on its FY 2020 After-Hours earnings guidance on Tuesday, March, 31st. The company provided earnings per share guidance of 0.16-0.20 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.22. The company issued revenue guidance of $580-590 million, compared to the consensus revenue estimate of $585.24 million.

What price target have analysts set for LNDC?

5 analysts have issued twelve-month price targets for Landec's shares. Their forecasts range from $10.00 to $15.00. On average, they anticipate Landec's stock price to reach $12.50 in the next year. This suggests a possible upside of 14.3% from the stock's current price. View analysts' price targets for Landec.

Has Landec been receiving favorable news coverage?

News stories about LNDC stock have been trending very positive recently, InfoTrie Sentiment reports. The research group ranks the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Landec earned a coverage optimism score of 4.0 on InfoTrie's scale. They also gave headlines about the basic materials company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutLandec.

Who are some of Landec's key competitors?

What other stocks do shareholders of Landec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Landec investors own include Honda Motor (HMC), Comerica (CMA), Cenovus Energy (CVE), Albemarle (ALB), General Electric (GE), General Mills (GIS), Exxon Mobil (XOM), Walt Disney (DIS), Ring Energy (REI) and Ring Energy (REI).

Who are Landec's key executives?

Landec's management team includes the following people:
  • Dr. Albert D. Bolles, CEO, Pres & Director (Age 62, Pay $506.71k)
  • Mr. Brian F. McLaughlin, Chief Financial Officer (Age 65, Pay $351.53k)
  • Mr. James G. Hall, VP (Age 57, Pay $455.55k)
  • Mr. Parker K. Javid, VP (Age 50, Pay $321.91k)
  • Mr. Timothy P. Burgess, Sr. VP of Operations

What is Landec's stock symbol?

Landec trades on the NASDAQ under the ticker symbol "LNDC."

Who are Landec's major shareholders?

Landec's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Russell Investments Group Ltd. (9.62%), Legion Partners Asset Management LLC (8.16%), BlackRock Inc. (6.93%), NWQ Investment Management Company LLC (6.61%), Investment Counselors of Maryland LLC (2.93%) and State Street Corp (1.95%). Company insiders that own Landec stock include Albert D Bolles, Catherine A Sohn, Gregory S Skinner, Nelson Obus, Steven D Goldby and Timothy P Burgess. View institutional ownership trends for Landec.

Which major investors are selling Landec stock?

LNDC stock was sold by a variety of institutional investors in the last quarter, including AltraVue Capital LLC, NWQ Investment Management Company LLC, Signia Capital Management LLC, Penn Capital Management Co. Inc., Russell Investments Group Ltd., Morgan Stanley, Two Sigma Advisers LP, and John G Ullman & Associates Inc.. View insider buying and selling activity for Landec.

Which major investors are buying Landec stock?

LNDC stock was bought by a variety of institutional investors in the last quarter, including Legion Partners Asset Management LLC, Invesco Ltd., Geode Capital Management LLC, Wells Fargo & Company MN, SG Americas Securities LLC, Fuller & Thaler Asset Management Inc., Engineers Gate Manager LP, and BlackRock Inc.. Company insiders that have bought Landec stock in the last two years include Albert D Bolles, Catherine A Sohn, Gregory S Skinner, Nelson Obus, Steven D Goldby, and Timothy P Burgess. View insider buying and selling activity for Landec.

How do I buy shares of Landec?

Shares of LNDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Landec's stock price today?

One share of LNDC stock can currently be purchased for approximately $10.94.

How big of a company is Landec?

Landec has a market capitalization of $319.23 million and generates $557.56 million in revenue each year. The basic materials company earns $410,000.00 in net income (profit) each year or $0.32 on an earnings per share basis. Landec employs 736 workers across the globe.

What is Landec's official website?

The official website for Landec is www.landec.com.

How can I contact Landec?

Landec's mailing address is 5201 GREAT AMERICA PKWY SUITE 232, SANTA CLARA CA, 95054. The basic materials company can be reached via phone at 650-306-1650 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.